Atlantic Family Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$379K Buy
13,486
+250
+2% +$6.66K 0.27% 27
2025
Q4
$330K Buy
13,236
+1,306
+11% +$32.9K 0.25% 31
2025
Q3
$304K Buy
11,930
+1,125
+10% +$27.8K 0.23% 36
2025
Q2
$262K Buy
+10,805
New +$252K 0.23% 34

Other funds holding PFE

Atlantic Family Wealth's PFE Position: Q1 2026 in Review

Atlantic Family Wealth increased its Pfizer (PFE) stake by 1.9% in Q1 2026, buying an estimated $6.66K and bringing the position to 13,486 shares worth $379K. The position accounts for 0.27% of the portfolio, ranked #27.

Atlantic Family Wealth first reported a position in PFE in Q2 2025 and has held it in 4 quarters since. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Atlantic Family Wealth held 13,486 shares of Pfizer worth $379K as of Q1 2026.
  • Atlantic Family Wealth bought 250 Pfizer shares in Q1 2026, an estimated $6.66K.
  • Pfizer made up 0.27% of Atlantic Family Wealth's portfolio in Q1 2026, its #27 holding.
  • Atlantic Family Wealth first reported a position in Pfizer in Q2 2025 and has held it in 4 quarters since.
  • 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Atlantic Family Wealth's 13F filing for Q1 2026, filed 8 May 2026.